The Health-NCP-Net organizes a webinar on 13th February 2017 (3.30-4.30 pm CET) about the support offered by InnovFin, providing information how this funding tool works and how it facilitates and accelerates access to finance for innovative businesses and other innovative entities in Europe.
One of the key factors constraining the implementation of R&I activities is the lack of available financing at acceptable terms to innovative businesses since these types of companies or projects deal with complex products and technologies, unproven markets and intangible assets. Henri-François Boedt, Senior Loan Officer, Growth Capital and Innovation Finance, European Investment Bank will provide insights on how investments in the development of innovative vaccines, drugs, medical and diagnostic devices or novel research infrastructures for infectious diseases can be stimulated.
Participation to this webinar is free of charge but pre-registration is required. Due to the limited places, the registrations will be accepted on the first come-first served basis. The participation of more than one person per institution may be discouraged.
Deadline for registration: 09.02.2017 (or full capacity);
Registration does not constitute automatic acceptance to the webinar. You will receive a confirmation email soon.
Registration is open under: http://www.healthncp.net/news-events/hnn-20-webinar-innovfin-infectious-diseases